The Latest in Huntington's Disease

Clinical Neurology News

Progression in Huntington’s linked to CAG repeat number

August 16, 2019

Clinical Neurology News

Huntington’s symptom domains correlate with structural differences

July 16, 2019

Clinical Neurology News

Novel genetic therapy reduces key protein in Huntington’s disease

June 12, 2019

Neurology Reviews

Mutant huntingtin and neurofilament light are potential biomarkers in Huntington’s disease

June 11, 2019

Neurology Reviews

Laquinimod may not improve motor function in Huntington’s disease

May 6, 2019

Neurology Reviews

Polyglutamine diseases are rare, but not the mutations that cause them

April 4, 2019

Clinical Neurology News

Huntington’s research returns to Latin America, as scientists tread with care

December 3, 2018

Clinical Neurology News

Huntington’s progression tracks with levels of mutant huntingtin, neurofilament light

September 12, 2018

Clinical Neurology News

VIDEO: Encouraging results reported for novel Huntington’s disease therapy

April 23, 2018

Clinical Neurology News

Gene silencer reduces mutant huntingtin protein in early-stage Huntington’s patients

December 12, 2017

Clinical Neurology News

Salivary biomarker identified for Huntington’s disease

November 13, 2017

Clinical Neurology News

Austedo approved for treatment of tardive dyskinesia

August 31, 2017

Clinical Neurology News

FDA approves deutetrabenazine for Huntington’s-associated chorea

April 4, 2017

Clinical Neurology News

Intermediate alleles may confer mild, late-onset Huntington-like symptoms

July 21, 2016

Clinical Neurology News

Deutetrabenazine modestly reduces chorea of Huntington disease

July 5, 2016